Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

SELECT

Novo Nordisk · Phase 3 · Completed · Enrollment 17604

NCT03574597

EudraCT 2017-003380-35

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutiden/rn/rn/rn/rn/r
Placebo (semaglutide)337 participants87 participants353 participantsn/r460

A count stays a count. This page does not turn a count into a percent.